Jeuveau Powder
Product Images NDC 72301-595

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Jeuveau (NDC 72301-595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Evolus, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1-2 (Image 01)

Illustration showing a close-up of eyes and eyebrows with marked injection sites indicated by 'X' above and between the eyebrows, spaced symmetrically around the glabellar region. Dotted lines and a scale indicating 1 cm are included to assist with precise intramuscular injection placement.*

FDA Label Image

Logo (Image 02)

FDA Label Image

Principal Display Panel (Carton Label)

The packaging label for Jeuveau 100 units vial displays prabotulinumtoxinA-xvfs for injection in powder form for intramuscular use. The label states it is a single-dose vial with no preservative, manufactured by Evolus, Inc. in Korea. Storage instructions specify refrigeration at 2° to 8°C, and warnings about dosing units and reconstitution details are included along with manufacturer and distributor information, a barcode, and a website link.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.